BR100 Increased By (0.49%)
BR30 Increased By (0.14%)
KSE100 Increased By (0.45%)
KSE30 Increased By (0.43%)
AGHA 7.76 Increased By ▲ 0.01 (0.13%)
BECO 5.19 No Change ▼ 0.00 (0%)
BML 57.42 Decreased By ▼ -1.24 (-2.11%)
BOP 34.15 Increased By ▲ 0.46 (1.37%)
CNERGY 10.46 Decreased By ▼ -0.15 (-1.41%)
CSIL 5.42 Increased By ▲ 0.12 (2.26%)
FCCL 54.82 Increased By ▲ 1.08 (2.01%)
FFL 16.71 Increased By ▲ 0.25 (1.52%)
FNEL 1.25 Increased By ▲ 0.03 (2.46%)
KEL 7.42 Increased By ▲ 0.14 (1.92%)
KOSM 5.76 Increased By ▲ 0.12 (2.13%)
LOTCHEM 29.50 Decreased By ▼ -0.15 (-0.51%)
MLCF 95.49 Decreased By ▼ -0.87 (-0.9%)
NBP 203.51 Decreased By ▼ -0.02 (-0.01%)
NCPL 57.96 Increased By ▲ 1.11 (1.95%)
NPL 68.89 Increased By ▲ 1.58 (2.35%)
OGDC 317.39 Decreased By ▼ -0.83 (-0.26%)
PACE 10.74 Increased By ▲ 0.11 (1.03%)
PAEL 42.81 Increased By ▲ 1.04 (2.49%)
PIBTL 16.84 Increased By ▲ 0.03 (0.18%)
PPL 220.99 Increased By ▲ 0.82 (0.37%)
PRL 50.73 Increased By ▲ 1.68 (3.43%)
PTC 70.69 Increased By ▲ 0.68 (0.97%)
SSGC 28.20 Decreased By ▼ -0.94 (-3.23%)
TBL 9.84 Increased By ▲ 0.07 (0.72%)
TELE 8.85 Increased By ▲ 0.03 (0.34%)
TPL 18.32 Increased By ▲ 1.15 (6.7%)
TPLP 12.90 Increased By ▲ 0.39 (3.12%)
TREET 22.79 Increased By ▲ 0.20 (0.89%)
TRG 59.92 Decreased By ▼ -0.30 (-0.5%)
World

Indonesia approves AstraZeneca vaccine for emergency use

  • About 38 million doses of a vaccine produced by China's Sinovac Biotech have arrived in the Southeast Asian country so far, some of which have been used in a mass inoculation drive starting in January.
Published Updated
By

JAKARTA: Indonesia has approved AstraZeneca's COVID-19 vaccine for emergency use, Penny K. Lukito, the chief of the country's food and drug agency, told a news conference on Tuesday.

More than one million doses of the vaccine arrived late on Monday via the COVAX global vaccine-alliance scheme.

About 38 million doses of a vaccine produced by China's Sinovac Biotech have arrived in the Southeast Asian country so far, some of which have been used in a mass inoculation drive starting in January.

Comments

Comments are closed for this article.